Pro-Calcitonin Levels Following Pediatric Cardiac Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00284570|
Recruitment Status : Completed
First Posted : February 1, 2006
Last Update Posted : November 27, 2013
First, we, the researchers, hope to find out the PCT response to heart surgery in children by taking blood before surgery and each day for four days after surgery. These blood draws will help us figure out the typical Procalcitonin (PCT) response, the normal increase in PCT after heart surgery, and when the PCT level returns to baseline.
Second, we, the researchers, hope to determine the accuracy of PCT as a marker of infection.
Our hypothesis is that Procalcitonin is superior to other currently used markers of infection and will prove to be a clinically useful tool for evaluation of infection in children following cardiac surgery.
|Condition or disease|
|Congenital Heart Disease Sepsis Infection|
|Study Type :||Observational|
|Actual Enrollment :||49 participants|
|Official Title:||ProCalcitonin in the Pediatric Surgical Patient, Evaluation of a New Marker of Infection|
|Study Start Date :||January 2006|
|Actual Study Completion Date :||March 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00284570
|United States, Georgia|
|Children's Healthcare of Atlanta|
|Atlanta, Georgia, United States, 30322|
|Principal Investigator:||Kevin Maher, MD||Emory University|